Farallon Capital Management’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-875,000	Closed	-$20.6M	–	106
2019 Q4	$20.6M	Buy	+875,000	New	+$20.6M	0.14%	82